Case Report
Published on 09 Nov 2022
Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report
in Cancer Molecular Targets and Therapeutics

- 1,479 views
Case Report
Published on 09 Nov 2022
in Cancer Molecular Targets and Therapeutics

Review
Published on 07 Nov 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 03 Nov 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 03 Nov 2022
in Cancer Molecular Targets and Therapeutics

Case Report
Published on 31 Oct 2022
in Cancer Molecular Targets and Therapeutics

Systematic Review
Published on 31 Oct 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 31 Oct 2022
in Cancer Molecular Targets and Therapeutics

Case Report
Published on 31 Oct 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 27 Oct 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 26 Oct 2022
in Cancer Molecular Targets and Therapeutics

Case Report
Published on 26 Oct 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 24 Oct 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 24 Oct 2022
in Cancer Molecular Targets and Therapeutics

Review
Published on 21 Oct 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 21 Oct 2022
in Cancer Molecular Targets and Therapeutics

Original Research
Published on 20 Oct 2022
in Cancer Molecular Targets and Therapeutics
